Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


Oliena Studio

Stroke and language recovery: 9000+ videos

EspañolItalianoSarduEnglish | PDF+


  Alzheimer's Disease

  Free Subscription


Articles published in J Neurol

Retrieve available abstracts of 34 articles:
HTML format
Text format



Single Articles


    July 2019
  1. ALTOMARE D, Ferrari C, Caroli A, Galluzzi S, et al
    Prognostic value of Alzheimer's biomarkers in mild cognitive impairment: the effect of age at onset.
    J Neurol. 2019 Jul 2. pii: 10.1007/s00415-019-09441.
    PubMed     Text format     Abstract available


  2. BROWN J, Wiggins J, Lansdall CJ, Dawson K, et al
    Test Your Memory (TYM test): diagnostic evaluation of patients with non-Alzheimer dementias.
    J Neurol. 2019 Jul 2. pii: 10.1007/s00415-019-09447.
    PubMed     Text format     Abstract available


    June 2019
  3. BRUEGGEN K, Dyrba M, Cardenas-Blanco A, Schneider A, et al
    Structural integrity in subjective cognitive decline, mild cognitive impairment and Alzheimer's disease based on multicenter diffusion tensor imaging.
    J Neurol. 2019 Jun 21. pii: 10.1007/s00415-019-09429.
    PubMed     Text format     Abstract available


  4. PERRI R, Monaco M, Fadda L, Caltagirone C, et al
    Influence of controlled encoding and retrieval facilitation on memory performance of patients with subcortical ischemic vascular dementia and Alzheimer's disease.
    J Neurol. 2019 Jun 18. pii: 10.1007/s00415-019-09411.
    PubMed     Text format     Abstract available


  5. BAYART JL, Hanseeuw B, Ivanoiu A, van Pesch V, et al
    Analytical and clinical performances of the automated Lumipulse cerebrospinal fluid Abeta42 and T-Tau assays for Alzheimer's disease diagnosis.
    J Neurol. 2019 Jun 10. pii: 10.1007/s00415-019-09418.
    PubMed     Text format     Abstract available


    May 2019
  6. TERADA T, Yokokura M, Obi T, Bunai T, et al
    In vivo direct relation of tau pathology with neuroinflammation in early Alzheimer's disease.
    J Neurol. 2019 May 28. pii: 10.1007/s00415-019-09400.
    PubMed     Text format     Abstract available


    April 2019
  7. SCHUMACHER J, Cromarty R, Gallagher P, Firbank MJ, et al
    Structural correlates of attention dysfunction in Lewy body dementia and Alzheimer's disease: an ex-Gaussian analysis.
    J Neurol. 2019 Apr 21. pii: 10.1007/s00415-019-09323.
    PubMed     Text format     Abstract available


  8. OKUDA S, Tetsuka J, Takahashi K, Toda Y, et al
    Association between sleep disturbance in Alzheimer's disease patients and burden on and health status of their caregivers.
    J Neurol. 2019 Apr 9. pii: 10.1007/s00415-019-09286.
    PubMed     Text format     Abstract available


  9. MANCA C, Rivasseau Jonveaux T, Roch V, Marie PY, et al
    Amyloid PETs are commonly negative in suspected Alzheimer's disease with an increase in CSF phosphorylated-tau protein concentration but an Abeta42 concentration in the very high range: a prospective study.
    J Neurol. 2019 Apr 8. pii: 10.1007/s00415-019-09315.
    PubMed     Text format     Abstract available


  10. SLACHEVSKY A, Forno G, Barraza P, Mioshi E, et al
    Mapping the neuroanatomy of functional decline in Alzheimer's disease from basic to advanced activities of daily living.
    J Neurol. 2019 Apr 4. pii: 10.1007/s00415-019-09260.
    PubMed     Text format     Abstract available


    February 2019
  11. MAZZEO S, Padiglioni S, Bagnoli S, Bracco L, et al
    The dual role of cognitive reserve in subjective cognitive decline and mild cognitive impairment: a 7-year follow-up study.
    J Neurol. 2019;266:487-497.
    PubMed     Text format     Abstract available


    January 2019
  12. JIN B, Liu H
    Comparative efficacy and safety of therapy for the behavioral and psychological symptoms of dementia: a systemic review and Bayesian network meta-analysis.
    J Neurol. 2019 Jan 21. pii: 10.1007/s00415-019-09200.
    PubMed     Text format     Abstract available


    November 2018
  13. DE SIMONE MS, Perri R, Fadda L, Caltagirone C, et al
    Predicting progression to Alzheimer's disease in subjects with amnestic mild cognitive impairment using performance on recall and recognition tests.
    J Neurol. 2018 Nov 1. pii: 10.1007/s00415-018-9108.
    PubMed     Text format     Abstract available


  14. AHMED RM, Goldberg ZL, Kaizik C, Kiernan MC, et al
    Neural correlates of changes in sexual function in frontotemporal dementia: implications for reward and physiological functioning.
    J Neurol. 2018;265:2562-2572.
    PubMed     Text format     Abstract available


    August 2018
  15. ONG SS, Proia AD, Whitson HE, Farsiu S, et al
    Ocular amyloid imaging at the crossroad of Alzheimer's disease and age-related macular degeneration: implications for diagnosis and therapy.
    J Neurol. 2018 Aug 28. pii: 10.1007/s00415-018-9028.
    PubMed     Text format     Abstract available


  16. PICKRELL WO, Robertson NP
    New treatments in Alzheimer's disease.
    J Neurol. 2018 Aug 21. pii: 10.1007/s00415-018-9018.
    PubMed     Text format    


  17. CHANDRA A, Dervenoulas G, Politis M
    Magnetic resonance imaging in Alzheimer's disease and mild cognitive impairment.
    J Neurol. 2018 Aug 17. pii: 10.1007/s00415-018-9016.
    PubMed     Text format     Abstract available


  18. BOUGEA A, Stefanis L, Paraskevas GP, Emmanouilidou E, et al
    Neuropsychiatric symptoms and alpha-Synuclein profile of patients with Parkinson's disease dementia, dementia with Lewy bodies and Alzheimer's disease.
    J Neurol. 2018 Aug 6. pii: 10.1007/s00415-018-8992.
    PubMed     Text format     Abstract available


  19. WEI H, Zhu X, Li Y
    Application value of serum biomarkers for choosing memantine therapy for moderate AD.
    J Neurol. 2018;265:1844-1849.
    PubMed     Text format     Abstract available


    April 2018
  20. ROALF DR, Rupert P, Mechanic-Hamilton D, Brennan L, et al
    Quantitative assessment of finger tapping characteristics in mild cognitive impairment, Alzheimer's disease, and Parkinson's disease.
    J Neurol. 2018 Apr 4. pii: 10.1007/s00415-018-8841.
    PubMed     Text format     Abstract available


    February 2018
  21. AVGERINOS KI, Kalaitzidis G, Malli A, Kalaitzoglou D, et al
    Intranasal insulin in Alzheimer's dementia or mild cognitive impairment: a systematic review.
    J Neurol. 2018 Feb 1. pii: 10.1007/s00415-018-8768.
    PubMed     Text format     Abstract available


    December 2017
  22. EDWARDS M, Robertson NP
    Seizures in Alzheimer's disease: is there more beneath the surface?
    J Neurol. 2017 Dec 4. pii: 10.1007/s00415-017-8694.
    PubMed     Text format    


    September 2017
  23. DE SIMONE MS, Perri R, Fadda L, De Tollis M, et al
    Different deficit patterns on word lists and short stories predict conversion to Alzheimer's disease in patients with amnestic mild cognitive impairment.
    J Neurol. 2017 Sep 25. doi: 10.1007/s00415-017-8623.
    PubMed     Text format     Abstract available


  24. LIGUORI C, Chiaravalloti A, Nuccetelli M, Izzi F, et al
    Hypothalamic dysfunction is related to sleep impairment and CSF biomarkers in Alzheimer's disease.
    J Neurol. 2017 Sep 12. doi: 10.1007/s00415-017-8613.
    PubMed     Text format     Abstract available


  25. CECCHINI MA, Yassuda MS, Bahia VS, de Souza LC, et al
    Recalling feature bindings differentiates Alzheimer's disease from frontotemporal dementia.
    J Neurol. 2017 Sep 11. doi: 10.1007/s00415-017-8614.
    PubMed     Text format     Abstract available


    August 2017
  26. KARAVASILIS E, Parthimos TP, Papatriantafyllou JD, Papageorgiou SG, et al
    A specific pattern of gray matter atrophy in Alzheimer's disease with depression.
    J Neurol. 2017 Aug 30. doi: 10.1007/s00415-017-8603.
    PubMed     Text format     Abstract available


  27. CAI Z, Wan CQ, Liu Z
    Astrocyte and Alzheimer's disease.
    J Neurol. 2017 Aug 18. doi: 10.1007/s00415-017-8593.
    PubMed     Text format     Abstract available


  28. HRASTELJ J, Robertson N
    Genetics of disease severity in multiple sclerosis, Alzheimer's disease, and Huntington's disease: rejuvenating genome-wide association studies.
    J Neurol. 2017 Aug 7. doi: 10.1007/s00415-017-8584.
    PubMed     Text format    


    January 2017
  29. MALIK GA, Robertson NP
    Treatments in Alzheimer's disease.
    J Neurol. 2017 Jan 24. doi: 10.1007/s00415-017-8395.
    PubMed     Text format    


    December 2016
  30. TYNKKYNEN J, Hernesniemi JA, Laatikainen T, Havulinna AS, et al
    High-sensitivity cardiac troponin I and NT-proBNP as predictors of incident dementia and Alzheimer's disease: the FINRISK Study.
    J Neurol. 2016 Dec 30. doi: 10.1007/s00415-016-8378.
    PubMed     Text format     Abstract available


  31. KIMURA A, Takemura M, Saito K, Yoshikura N, et al
    Comparison of cerebrospinal fluid profiles in Alzheimer's disease with multiple cerebral microbleeds and cerebral amyloid angiopathy-related inflammation.
    J Neurol. 2016 Dec 20. doi: 10.1007/s00415-016-8362.
    PubMed     Text format     Abstract available


    October 2016
  32. CASTRO P, Zaman S, Holland A
    Alzheimer's disease in people with Down's syndrome: the prospects for and the challenges of developing preventative treatments.
    J Neurol. 2016.
    PubMed     Text format     Abstract available


  33. BORRELLO L, Cupidi C, Lagana V, Anfossi M, et al
    Angela R.: a familial Alzheimer's disease case in the days of Auguste D.
    J Neurol. 2016.
    PubMed     Text format     Abstract available


    May 2016
  34. MASCALCHI M, Bessi V, Ginestroni A, Toschi N, et al
    Low MT ratio in hippocampus of amnestic MCI patients who will progress to AD.
    J Neurol. 2016;263:1024-6.
    PubMed     Text format    


Thank you for your interest in scientific medicine.


AMEDEO Alzheimer's Disease is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: